Parabilis Leads the Charge in Biotech Fundraising with $305 Million to Propel Cancer Drug Development

Parabilis Leads the Charge in Biotech Fundraising with $305 Million to Propel Cancer Drug Development

Parabilis Leads the Charge in Biotech Fundraising with $305 Million to Propel Cancer Drug Development